Improving Patient Safety & Extending Market Lifespan Through Lifecycle Management

A project that began as a formulation development challenge evolved into a strategic lifecycle management opportunity. Kiel Laboratories’ expertise helped reduce patient risk and extend market value for a liquid formulation of baclofen.  

Download our case study to explore: 

• How our work mitigated a critical patient safety risk without disrupting the product’s established therapeutic effect 
• Strategies used to balance regulatory, patient, and commercial priorities  
• Steps taken to improve the formulation as part of the lifecycle management strategy 
• Key outcomes of the partnership, including regulatory process and expanded market potential 

Get Your Copy Now

Back to Resources